BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 5558653)

  • 1. Criteria for the evaluation of the severity of established renal disease. Council on the Kidney in Cardiovascular disease. American Heart Association, 1971.
    Ann Intern Med; 1971 Aug; 75(2):251-2. PubMed ID: 5558653
    [No Abstract]   [Full Text] [Related]  

  • 2. Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trial.
    Ruilope LM; Zanchetti A; Julius S; McInnes GT; Segura J; Stolt P; Hua TA; Weber MA; Jamerson K;
    J Hypertens; 2007 Jul; 25(7):1473-9. PubMed ID: 17563571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive treatment and glomerular size selectivity in hypertensive patients with renal parenchymal disease and proteinuria.
    Shand BI; Lewis JG; Elder PA; Agarwal M
    Clin Nephrol; 2002 Oct; 58(4):321-4. PubMed ID: 12400851
    [No Abstract]   [Full Text] [Related]  

  • 4. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic kidney disease and global cardiovascular risk in essential hypertension.
    Segura J; Campo C; Ruilope LM
    Minerva Med; 2004 Oct; 95(5):375-83. PubMed ID: 15467513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Glomerular filtration rate and cardiovascular risk: prognostic and therapeutic implications].
    Ratto E; Leoncini G; Viazzi F; Pontremoli R
    G Ital Nefrol; 2008; 25(1):21-31. PubMed ID: 18264915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trio of kidney disease signs takes toll on heart.
    Harv Heart Lett; 2005 May; 15(9):7. PubMed ID: 15898151
    [No Abstract]   [Full Text] [Related]  

  • 8. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.
    Sarnak MJ; Levey AS; Schoolwerth AC; Coresh J; Culleton B; Hamm LL; McCullough PA; Kasiske BL; Kelepouris E; Klag MJ; Parfrey P; Pfeffer M; Raij L; Spinosa DJ; Wilson PW;
    Circulation; 2003 Oct; 108(17):2154-69. PubMed ID: 14581387
    [No Abstract]   [Full Text] [Related]  

  • 9. [Proposal for standardized criteria in the evaluation of kidney disease stages].
    Dölle W
    Internist (Berl); 1971 Mar; 12(3):100-2. PubMed ID: 4927711
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: a science advisory from the American Heart Association Kidney And Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: developed in collaboration with the National Kidney Foundation.
    Brosius FC; Hostetter TH; Kelepouris E; Mitsnefes MM; Moe SM; Moore MA; Pennathur S; Smith GL; Wilson PW; ; ; ; ;
    Circulation; 2006 Sep; 114(10):1083-7. PubMed ID: 16894032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic renal disease. Primary care identification].
    Hanset M
    Rev Med Brux; 2007; 28(5):465-8. PubMed ID: 18069523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring filtration function in clinical practice.
    Fawaz A; Badr KF
    Curr Opin Nephrol Hypertens; 2006 Nov; 15(6):643-7. PubMed ID: 17053481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study.
    Imai E; Horio M; Yamagata K; Iseki K; Hara S; Ura N; Kiyohara Y; Makino H; Hishida A; Matsuo S
    Hypertens Res; 2008 Mar; 31(3):433-41. PubMed ID: 18497462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal abnormalities that cause hypertension versus those that cause uraemia.
    Guyton AC; Manning RD; Hall JE; Young DB
    Neth J Med; 1984; 27(4):117-23. PubMed ID: 6377101
    [No Abstract]   [Full Text] [Related]  

  • 16. Nephronophthisis (medullary cystic disease of the kidney) with proteinuria and hypertension--an atypical presentation of a rare kidney disease.
    Youmbissi Tchetagni J; Mabakop A
    West Afr J Med; 1989; 8(1):87-8. PubMed ID: 2486778
    [No Abstract]   [Full Text] [Related]  

  • 17. Early diagnosis of CKD and its prevention.
    Amaresan MS; Geetha R
    J Assoc Physicians India; 2008 Jan; 56():41-6. PubMed ID: 18472500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minor abnormalities of renal function: a situation requiring integrated management of cardiovascular risk.
    Segura J; Ruilope LM
    Fundam Clin Pharmacol; 2005 Aug; 19(4):429-37. PubMed ID: 16011729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between kidney function, proteinuria, and adverse outcomes--a critical look at the application of medical statistics in the Nephrology literature.
    Onuigbo MA
    QJM; 2010 Jul; 103(7):537-8. PubMed ID: 20385569
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of hypertension in renal parenchymal diseases].
    Iversen BM; Kvam FI; Svarstad E
    Tidsskr Nor Laegeforen; 1996 Jun; 116(17):2022-6. PubMed ID: 8766645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.